levodopa has been researched along with Amyotonia Congenita in 9 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 6 (66.67) | 18.7374 |
| 1990's | 2 (22.22) | 18.2507 |
| 2000's | 1 (11.11) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Hattori, N | 1 |
| Fahn, S; Jiang, D; Reches, A | 1 |
| Bugiani, O; Gatti, R | 1 |
| Bannister, R; Mackay, AV; Quik, M; Spokes, EG | 1 |
| Ciobanu, M; Cozma, V; Oprişan, C; Pendefunda, G | 1 |
| Dickey, W; Morrow, JI | 1 |
| Comella, CL; Diederich, N; Goetz, CG | 1 |
| Bill, PL; Cosnett, JE | 1 |
| De Keyser, J | 1 |
3 review(s) available for levodopa and Amyotonia Congenita
| Article | Year |
|---|---|
[Neuromuscular disorders due to adverse effects of antiparkinson agents].
Topics: Amantadine; Antiparkinson Agents; Catechols; Dopamine Agonists; Humans; Levodopa; Monoamine Oxidase Inhibitors; Neuromuscular Diseases; Nitriles; Trihexyphenidyl | 2007 |
Drug-induced neurological disorders.
Topics: Antihypertensive Agents; Aspirin; Brain Diseases; Dyskinesia, Drug-Induced; Humans; Levodopa; Nervous System Diseases; Neuromuscular Diseases | 1990 |
New approaches in the treatment of the dystonias.
Topics: Botulinum Toxins; Diagnosis, Differential; Dopamine Antagonists; Dystonia; Humans; Levodopa; Neuromuscular Diseases; Neurosurgery; Parasympatholytics | 1990 |
6 other study(ies) available for levodopa and Amyotonia Congenita
| Article | Year |
|---|---|
Normal erythrocyte uptake of L-DOPA in Parkinson's, Huntington's, and related diseases.
Topics: Biological Transport; Erythrocytes; Humans; Huntington Disease; Levodopa; Neuromuscular Diseases; Parkinson Disease | 1983 |
L-Dopa in children with progressive neurological disorders.
Topics: Child; Humans; Levodopa; Male; Neuromuscular Diseases | 1980 |
Alterations in [3H]spiperone binding in human caudate nucleus, substantia nigra and frontal cortex in the Shy-Drager syndrome and Parkinson's disease.
Topics: Binding Sites; Butyrophenones; Caudate Nucleus; Cerebral Cortex; Frontal Lobe; Humans; Levodopa; Muscular Atrophy; Neuromuscular Diseases; Parkinson Disease; Receptors, Dopamine; Spiperone; Substantia Nigra; Syndrome | 1979 |
Clinico-electromyographic considerations on a case of neuromyotonia.
Topics: Adult; Electromyography; Female; Humans; Levodopa; Muscle Contraction; Myotonia; Neuromuscular Diseases; Phenytoin; Syndrome | 1975 |
Parkinson's disease in blacks. Observations on epidemiology in Natal.
Topics: Age Factors; Aged; Aged, 80 and over; Black People; Ethnicity; Humans; Levodopa; Middle Aged; Motor Neurons; Neuromuscular Diseases; Parkinson Disease; South Africa; White People | 1988 |
Treatment with levodopa of motor dysfunction in the elderly.
Topics: Aged; Aging; Humans; Levodopa; Motor Neurons; Neuromuscular Diseases; Receptors, Dopamine | 1986 |